Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link. Eli Lilly and Company ( LLY) pushed the Drugs industry lower today making it today's featured Drugs laggard. The industry as a whole closed the day up 0.5%. By the end of trading, Eli Lilly and Company fell $0.61 (-1.1%) to $52.43 on average volume. Throughout the day, 5,257,755 shares of Eli Lilly and Company exchanged hands as compared to its average daily volume of 4,840,000 shares. The stock ranged in price between $52.33-$53.09 after having opened the day at $52.99 as compared to the previous trading day's close of $53.04. Other companies within the Drugs industry that declined today were: BioScrip ( BIOS), down 18.6%, Mirati Therapeutics ( MRTX), down 12.1%, ImmuCell Corporation ( ICCC), down 10.5% and Amyris ( AMRS), down 10.2%.
- EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass
- You can view the full Eli Lilly and Company Ratings Report.
- Use our drugs section to find industry-relevant news.
- Or find some new ideas from our top rated stocks lists.
- Find other investment ideas from our top rated ETFs lists.